Dr. Alloo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1991 Marcus Avenue
Suite 300
New Hyde Park, NY 11042Phone+1 516-719-3376Fax+1 516-321-8514
Education & Training
- Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 2013 - 2016
- NYU Grossman Long Island School of MedicineInternship, Internal Medicine, 2012 - 2013
- Harvard Medical SchoolClass of 2012
Certifications & Licensure
- NY State Medical License 2016 - 2026
- MA State Medical License 2013 - 2016
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature.Christopher Iriarte, Jennifer E Yeh, Allireza Alloo, Christina Boull, Valerie M Carlberg
Supportive Care in Cancer. 2024-08-23 - 1 citationsOutcome Measurement Instruments Used to Evaluate Dermatologic Adverse Events in Cancer Trials: A Systematic Review.Sheila Shaigany, Nicole Mastacouris, Nicole Mastacouris, Rachel Tannenbaum, Andrew Strunk
JAMA Dermatology. 2024-06-01 - 2 citationsDefining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.Steven T Chen, Yevgeniy R Semenov, Allireza Alloo, Daniel Q Bach, Allison Betof Warner
Journal for Immunotherapy of Cancer. 2024-04-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: